Literature DB >> 25216440

Primary enteric-type mucinous adenocarcinoma of the urethra in a patient with ulcerative colitis.

Dimitrios Dimitroulis1, Dimitrios Patsouras, Athanasios Katsargyris, Petros Charalampoudis, Ioannis Anastasiou, Gregory Kouraklis.   

Abstract

Primary carcinoma of the male urethra accounts for less than 1% of malignancies in men. Mucinous adenocarcinoma of the urethra is extremely rare, and its biologic behavior is poorly understood. We present herein a rare case of mucinous urethral adenocarcinoma in a male patient with longstanding ulcerative colitis and multiple sclerosis. The patient presented with a voluminous pelvic mass; core biopsy of the lesion demonstrated a mucus-producing adenocarcinoma. Given the patient's history of subtotal colectomy, preoperative diagnosis was oriented towards a rectal stump adenocarcinoma. The patient underwent a pelvic exenteration: surprisingly, histology marked the prostatic urethra as the primary lesion site.

Entities:  

Keywords:  Adenocarcinoma; Mucinous; Ulcerative colitis; Urethra

Mesh:

Year:  2014        PMID: 25216440      PMCID: PMC4253943          DOI: 10.9738/INTSURG-D-13-00073.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  17 in total

1.  Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases.

Authors:  P Asten; J Barrett; D Symmons
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

2.  Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation.

Authors:  A G Sheil; A P Disney; T H Mathew; B E Livingston; A M Keogh
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

3.  Female urethral adenocarcinoma arising from urethritis glandularis.

Authors:  Y M Chan; D Ka-Leung Cheng; A Nga-Yin Cheung; H Yuen-Sheung Ngan; L C Wong
Journal:  Gynecol Oncol       Date:  2000-12       Impact factor: 5.482

4.  Association of ulcerative colitis with multiple sclerosis.

Authors:  E H Rang; B N Brooke; J Hermon-Taylor
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

Review 5.  Can we alter the natural history of Crohn disease in children?

Authors:  Jeffrey S Hyams; James F Markowitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-03       Impact factor: 2.839

6.  Adenocarcinoma of Skene's duct associated with a systemic coagulopathy.

Authors:  R N Taylor; C G Lacey; M A Shuman
Journal:  Gynecol Oncol       Date:  1985-10       Impact factor: 5.482

7.  A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic.

Authors:  L J Edwards; C S Constantinescu
Journal:  Mult Scler       Date:  2004-10       Impact factor: 6.312

8.  Malignant neoplasm in kidney transplantation.

Authors:  H Kishikawa; Y Ichikawa; K Yazawa; T Hanafusa; T Fukunishi; C Ebisui; A Okuyama; S Nagano
Journal:  Int J Urol       Date:  1998-11       Impact factor: 3.369

9.  Malignant disease in patients with long-term renal transplants.

Authors:  S B Gaya; A J Rees; R I Lechler; G Williams; P D Mason
Journal:  Transplantation       Date:  1995-06-27       Impact factor: 4.939

10.  Use of azathioprine and the risk of cancer in inflammatory bowel disease.

Authors:  Björn Pasternak; Henrik Svanström; Kjeld Schmiegelow; Tine Jess; Anders Hviid
Journal:  Am J Epidemiol       Date:  2013-03-20       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.